Soroka

Beersheba 84101

1 studies enrolling now · 2 studies all time

What they study most

Non-Hodgkin Lymphoma, Relapsed/Refractory Aggressive B-Cell Lymphoma

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma — Recruiting now
• A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies — Completed